Don't think it says "fail", but definitely doesn't say 'success'
Market just says , no money to be made from vaccines for a long time if.
They will need to prioritise now. in the immunotherapies. The company does not earn enough to fund everything in the pipe.
Short to medium term its all adapt and medical devices.
No need to pump immunology for now, it is what it is.
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-61
-
-
- There are more pages in this discussion • 290 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.30 |
Change
0.000(0.00%) |
Mkt cap ! $323.4M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 86 | $15.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.51 | 897 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 86 | 15.030 |
2 | 112 | 15.020 |
1 | 15 | 15.010 |
2 | 582 | 15.000 |
1 | 1000 | 14.850 |
Price($) | Vol. | No. |
---|---|---|
15.510 | 897 | 2 |
15.520 | 25 | 1 |
15.570 | 779 | 1 |
15.930 | 250 | 1 |
15.940 | 554 | 1 |
Last trade - 10.00am 20/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable